AVITA Medical, Inc. (RCEL)
NASDAQ: RCEL · Real-Time Price · USD
3.920
-0.010 (-0.25%)
Feb 6, 2026, 10:31 AM EST - Market open

AVITA Medical Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2021
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Jun '21
120338352166299511
Market Cap Growth
-45.98%-4.00%111.74%-44.28%-41.54%-22.10%
Enterprise Value
14233929579190398
Last Close Price
3.9312.8013.726.6011.9820.52
PS Ratio
1.455.267.034.839.0417.47
PB Ratio
-75.177.181.962.854.42
P/TBV Ratio
--7.251.972.874.43
EV/Sales Ratio
1.965.285.882.305.7713.60
Debt / Equity Ratio
-6.7210.220.870.010.020.01
Asset Turnover
1.000.670.480.32-0.28
Inventory Turnover
1.751.412.022.84-4.29
Quick Ratio
0.522.377.357.869.7016.05
Current Ratio
0.672.837.888.1810.0716.42
Return on Equity (ROE)
-1746.27%-230.96%-52.89%-28.16%--28.27%
Return on Assets (ROA)
-36.33%-36.97%-25.40%-16.05%--15.95%
Return on Capital Employed (ROCE)
-2218.40%-95.00%-43.30%-31.40%-23.50%-22.50%
Earnings Yield
-40.33%-18.29%-10.04%-16.03%-8.42%-5.21%
FCF Yield
-30.84%-17.18%-11.18%-11.75%-6.20%-5.25%
Buyback Yield / Dilution
-4.20%-2.18%-1.32%-2.64%-7.42%-11.75%
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q